Zachariah DeFilipp, MD

Explore the complexities of interpreting clinical trial results versus real-world experiences in chronic GVHD treatment options.

Explore effective third-line treatments for chronic GVHD, focusing on the latest FDA-approved therapies and their impact on patient outcomes.

Explore effective management strategies for chronic graft-versus-host disease, focusing on transitioning from steroids to second-line therapies like ruxolitinib.

A patient with chronic graft-versus-host disease faces treatment challenges, highlighting the need for effective management strategies post-transplant.

Explore the complexities of assessing chronic graft-versus-host disease severity and the role of NIH criteria in treatment decisions.

Dr. DeFilipp explores innovative strategies for managing chronic graft-versus-host disease, emphasizing personalized treatment and the shift towards targeted therapies.